Early vs late administration of icatibant in patients with hereditary angioedema

被引:0
|
作者
Zanichelli, A. [1 ]
Maurer, M. [2 ]
Aberer, W. [3 ]
Caballero, T. [4 ]
Bouillet, L. [5 ]
Bygum, A. [6 ]
Grumach, A. S. [7 ]
Botha, J. [8 ]
Andresen, I [8 ]
Longhurst, H. J. [9 ]
机构
[1] Univ Milan, Luigi Sacco Hosp, Milan, Italy
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Med Univ Graz, Graz, Austria
[4] Hosp La Paz Inst Hlth Res IdiPaz, Biomed Res Network Rare Dis CIBERER U754, Madrid, Spain
[5] Grenoble Univ Hosp, Grenoble, France
[6] Odense Univ Hosp, Odense, Denmark
[7] Fac Med ABC, Sao Paulo, Brazil
[8] Shire, Zug, Switzerland
[9] Barts Hlth NHS Trust, London, England
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
1427
引用
收藏
页码:721 / 722
页数:2
相关论文
共 50 条
  • [21] Are hereditary angioedema patients satisfied with on-demand therapy with icatibant?
    Beyaz, Sengul
    Demir, Semra
    Oztop, Nida
    Colakoglu, Bahauddin
    Buyukozturk, Suna
    Gelincik, Asli
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 357 - 357
  • [22] Self-administration of icatibant in acute attacks of Type I hereditary angioedema: A case report and review of hereditary angioedema
    Piras, Viviana
    Alves, Francisca
    Goncalo, Margarida
    DERMATOLOGIC THERAPY, 2019, 32 (06)
  • [23] Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema
    Farkas, Henriette
    Reshef, Avner
    Aberer, Werner
    Caballero, Teresa
    McCarthy, Laura
    Hao, James
    Nothaft, Wolfram
    Schranz, Jennifer
    Bernstein, Jonathan A.
    Li, H. Henry
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (06): : 1671 - +
  • [24] Treatment of submucosal hereditary angioedema attacks with icatibant
    Csuka, D.
    Zotter, Z.
    Varga, L.
    Boeroecz, Z.
    Temesszentandrasi, G.
    Jakab, L.
    Karadi, I
    Farkas, H.
    ALLERGY, 2011, 66 : 426 - 427
  • [25] Experiences with Icatibant in Adolescent Girl with Hereditary Angioedema
    Jesenak, M.
    Banovcin, P.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S352 - S352
  • [26] Icatibant: only in the treatment of hereditary angioedema attacks?
    Fernandes, M.
    Lourenco, T.
    Spinola Santos, A.
    Lopes, A.
    Cosme, J.
    Marcelino, J.
    Ferreira, R.
    Aguiar, R.
    Pestana, L.
    Almeida, P.
    Caiado, J.
    Duarte, F.
    Neto, M.
    Costa, A. C.
    Alonso, E.
    Branco Ferreira, M.
    Pedro, E.
    Barbosa, M.
    ALLERGY, 2017, 72 : 452 - 452
  • [27] Hereditary angioedema: epidemiology, management, and role of icatibant
    Ghazi, Aasia
    Grant, J. Andrew
    BIOLOGICS-TARGETS & THERAPY, 2013, 7 : 103 - 113
  • [28] The Icatibant Outcome Survey: Characteristics Of Patients With Hereditary Angioedema Requiring Reinjection
    Longhurst, Hilary
    Maurer, Marcus
    Fabien, Vincent
    Aberer, Werner
    Bouillet, Laurence
    Zanichelli, Andrea
    Caballero, Teresa
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB34 - AB34
  • [29] History of Misdiagnosis in Patients with Hereditary Angioedema Participating in the Icatibant Outcome Survey
    Zanichelli, Andrea
    Longhurst, Hilary
    Maurer, Marcus
    Bouillet, Laurence
    Aberer, Werner
    Fabien, Vincent
    Caballero, Teresa
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB194 - AB194
  • [30] Icatibant as acute treatment for hereditary angioedema in adults
    Farkas, Henriette
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (06) : 779 - 788